(Q34891212)

English

KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: a biomarker of cancer biology or a byproduct of patient selection?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

0 references

KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: a biomarker of cancer biology or a byproduct of patient selection? (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

0 references

1 reference

based on heuristic

inferred from title

liver metastasis

1 reference

based on heuristic

inferred from title

Kjetil Søreide

object named as

Kjetil Søreide

1

0 references

author name string

Oddvar M Sandvik

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Jon A Søreide

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

25 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

120

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

3862-3865

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

Hepatic resection for colorectal metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

From multidisciplinary to personalized treatment of colorectal liver metastases: 4 reasons to consider RAS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

Surgical management of disappearing colorectal liver metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I-III colon cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4288986

8 July 2018

Changing patterns of recurrent disease in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28979

21 January 2018

Effect of specialist decision-making on treatment strategies for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28979

21 January 2018

Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28979

21 January 2018

KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28979

21 January 2018

KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28979

21 January 2018

Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28979

21 January 2018

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25155780

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.28979

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34891212&oldid=1980113572"